The injectable drug Ozempic, a diabetes medication sometimes prescribed off-label for weight loss, is shown in Houston on July 1, 2023. David J. Phillip/File/AP Photo
Novo Nordisk says it will offer lower-priced Ozempic to some Canadian customers through a new savings program as generic versions of the diabetes and weight-loss drug enter the Canadian market.
Eligible Canadians without public or private drug coverage will be able to buy Ozempic for a lower price at pharmacies outside of Quebec using a savings card, the company said in a news release on May 26.
